108 related articles for article (PubMed ID: 3494736)
1. 2-Mercaptoethanol acts at the restricted stage of interleukin-2 dependent lymphocyte proliferation.
Sugama K; Namba Y; Hatanaka M; Hanaoka M
J Cell Physiol; 1987 Apr; 131(1):23-8. PubMed ID: 3494736
[TBL] [Abstract][Full Text] [Related]
2. 2-Mercaptoethanol acts as a potentiating factor of interleukin-2-dependent lymphocyte proliferation.
Sugama K; Namba Y; Hatanaka M; Hanaoka M
Microbiol Immunol; 1987; 31(7):691-700. PubMed ID: 3501822
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
Stoeck M; Northoff H; Resch K
J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines.
Olabuenaga SE; Brooks CG; Gillis S; Henney CS
J Immunol; 1983 Nov; 131(5):2386-91. PubMed ID: 6605387
[TBL] [Abstract][Full Text] [Related]
5. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
6. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
Teh HS; Yu M
J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
[TBL] [Abstract][Full Text] [Related]
7. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
Suzuki R; Handa K; Itoh K; Kumagai K
J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
[TBL] [Abstract][Full Text] [Related]
8. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrophages on the go-gl and gl-S transition of thymocytes.
Bettens F; Kristensen F; DeWeck AL
Immunology; 1982 Feb; 45(2):199-205. PubMed ID: 6800937
[TBL] [Abstract][Full Text] [Related]
10. Concanavalin A-stimulated rat spleen cells produce a soluble factor that supports growth of the mouse IL-3-dependent cell line Ea3.123, but not three other IL-3-dependent lines.
Carron JA; Marshall-Clarke S
Immunology; 1986 Aug; 58(4):635-40. PubMed ID: 3089920
[TBL] [Abstract][Full Text] [Related]
11. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
12. Separable helper factors support B cell proliferation and maturation to Ig secretion.
Parker DC
J Immunol; 1982 Aug; 129(2):469-74. PubMed ID: 6806371
[TBL] [Abstract][Full Text] [Related]
13. Response of bovine intestinal leukocytes to recombinant bovine interleukin-2.
Nagi AM; Babiuk LA
J Biol Regul Homeost Agents; 1988; 2(3):125-33. PubMed ID: 3267103
[TBL] [Abstract][Full Text] [Related]
14. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
Ouyang YL; Azcona-Olivera JI; Murtha J; Pestka JJ
Toxicol Appl Pharmacol; 1996 Jun; 138(2):324-34. PubMed ID: 8658534
[TBL] [Abstract][Full Text] [Related]
15. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
Yamauchi A; Bloom ET
J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
[TBL] [Abstract][Full Text] [Related]
16. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
Falk W; Männel DN; Dröge W
J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
[TBL] [Abstract][Full Text] [Related]
17. Humoral primary immune response in vitro in a homologous mouse system: replacement of fetal calf serum by a 2-mercaptoethanol or macrophage-activated fraction of mouse serum.
Opitz HG; Opitz U; Lemke H; Flad HD; Hewlett G; Schlumberger HD
J Immunol; 1977 Dec; 119(6):2089-94. PubMed ID: 334983
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of activation and suppression in rat Nb 2 lymphoma cells: a model for interactions between prolactin and the immune system.
Bates LG; Grove DS; Mastro AM
Exp Cell Res; 1995 Jun; 218(2):567-72. PubMed ID: 7796891
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival.
Gonzalez J; Harris T; Childs G; Prystowsky MB
Blood Cells Mol Dis; 2001; 27(3):572-85. PubMed ID: 11355896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
